88 related articles for article (PubMed ID: 21604544)
1. [Microbial NAD synthetase and its inhibitors--a review].
Bi J; Wang H; Xie J
Wei Sheng Wu Xue Bao; 2011 Mar; 51(3):305-12. PubMed ID: 21604544
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.
Velu SE; Mou L; Luan CH; Yang ZW; DeLucas LJ; Brouillette CG; Brouillette WJ
J Med Chem; 2007 May; 50(11):2612-21. PubMed ID: 17489580
[TBL] [Abstract][Full Text] [Related]
3. Structural adaptation of an interacting non-native C-terminal helical extension revealed in the crystal structure of NAD+ synthetase from Bacillus anthracis.
McDonald HM; Pruett PS; Deivanayagam C; Protasevich II; Carson WM; DeLucas LJ; Brouillette WJ; Brouillette CG
Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):891-905. PubMed ID: 17642516
[TBL] [Abstract][Full Text] [Related]
4. A nuclear magnetic resonance-based functional assay for nicotinamide adenine dinucleotide synthetase.
Stockman BJ; Lodovice IJ; Fisher DA; McColl AS; Xie Z
J Biomol Screen; 2007 Jun; 12(4):457-63. PubMed ID: 17379856
[TBL] [Abstract][Full Text] [Related]
5. Tethered dimers as NAD synthetase inhibitors with antibacterial activity.
Velu SE; Cristofoli WA; Garcia GJ; Brouillette CG; Pierson MC; Luan CH; DeLucas LJ; Brouillette WJ
J Med Chem; 2003 Jul; 46(15):3371-81. PubMed ID: 12852767
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
[TBL] [Abstract][Full Text] [Related]
7. An enzymatic cycling assay for nicotinic acid adenine dinucleotide phosphate using NAD synthetase.
Yamaguchi F; Ohshima T; Sakuraba H
Anal Biochem; 2007 May; 364(2):97-103. PubMed ID: 17395143
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets.
Bi J; Wang H; Xie J
J Cell Physiol; 2011 Feb; 226(2):331-40. PubMed ID: 20857400
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of NAD synthetase from methicillin-resistant Staphylococcus aureus.
Arbade GK; Srivastava SK
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):763-9. PubMed ID: 26057809
[TBL] [Abstract][Full Text] [Related]
10. Validation of NAD synthase inhibitors for inhibiting the cell viability of
Mandal H; Vijayakumar S; Yadav S; Kumar Singh S; Das P
J Biomol Struct Dyn; 2019 Oct; 37(17):4481-4493. PubMed ID: 30526395
[TBL] [Abstract][Full Text] [Related]
11. Tethered dimer inhibitors of NAD synthetase: parallel synthesis of an aryl-substituted SAR library.
Velu SE; Luan CH; Delucas LJ; Brouillette CG; Brouillette WJ
J Comb Chem; 2005; 7(6):898-904. PubMed ID: 16283799
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria.
Rodionova IA; Schuster BM; Guinn KM; Sorci L; Scott DA; Li X; Kheterpal I; Shoen C; Cynamon M; Locher C; Rubin EJ; Osterman AL
mBio; 2014 Feb; 5(1):. PubMed ID: 24549842
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani.
Saudagar P; Dubey VK
Biol Chem; 2011 Dec; 392(12):1113-22. PubMed ID: 22050226
[TBL] [Abstract][Full Text] [Related]
14. NAD(P) biosynthesis enzymes as potential targets for selective drug design.
Magni G; Di Stefano M; Orsomando G; Raffaelli N; Ruggieri S
Curr Med Chem; 2009; 16(11):1372-90. PubMed ID: 19355893
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).
Moro WB; Yang Z; Kane TA; Brouillette CG; Brouillette WJ
Bioorg Med Chem Lett; 2009 Apr; 19(7):2001-5. PubMed ID: 19249205
[TBL] [Abstract][Full Text] [Related]
16. Saccharomyces cerevisiae QNS1 codes for NAD(+) synthetase that is functionally conserved in mammals.
Suda Y; Tachikawa H; Yokota A; Nakanishi H; Yamashita N; Miura Y; Takahashi N
Yeast; 2003 Aug; 20(11):995-1005. PubMed ID: 12898714
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of NH3-dependent NAD+ synthetase from Helicobacter pylori.
Kang GB; Kim YS; Im YJ; Rho SH; Lee JH; Eom SH
Proteins; 2005 Mar; 58(4):985-8. PubMed ID: 15645437
[No Abstract] [Full Text] [Related]
18. Structural study of Escherichia coli NAD synthetase: overexpression, purification, crystallization, and preliminary crystallographic analysis.
Ozment C; Barchue J; DeLucas LJ; Chattopadhyay D
J Struct Biol; 1999 Oct; 127(3):279-82. PubMed ID: 10544053
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of active-site loops in NH3-dependent NAD+ synthetase from Bacillus subtilis.
Devedjiev Y; Symersky J; Singh R; Jedrzejas M; Brouillette C; Brouillette W; Muccio D; Chattopadhyay D; DeLucas L
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):806-12. PubMed ID: 11375500
[TBL] [Abstract][Full Text] [Related]
20. Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain.
Bellinzoni M; Buroni S; Pasca MR; Guglierame P; Arcesi F; De Rossi E; Riccardi G
Res Microbiol; 2005 Mar; 156(2):173-7. PubMed ID: 15748981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
